Neuroimmune mechanisms in Alzheimer disease pathogenesis

Alzheimer Dis Assoc Disord. 1994 Fall;8(3):149-58. doi: 10.1097/00002093-199408030-00001.

Abstract

Lesions in Alzheimer disease are characterized by the assembly of a variety of cells and proteins associated with the immune system. Activated microglia express high levels of major histocompatibility complex glycoproteins and receptors for complement. Small numbers of T lymphocytes infiltrate tissue. Proteins of the classical complement pathway are closely connected with beta-amyloid deposits. beta-Amyloid protein binds C1q in vitro and activates the pathway. The membrane attack complex of complement, as well as proteins that defend against that complex, colocalize with dystrophic neurites. These data imply that an autodestructive process is occurring in Alzheimer disease, that overactive microglia might be responsible, and that antiinflammatory drugs might be an effective form of therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / immunology*
  • Amyloid beta-Peptides / metabolism
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology*
  • Complement Activation / drug effects
  • Complement Activation / physiology
  • Complement Membrane Attack Complex / metabolism
  • Humans
  • Microglia / immunology
  • Nerve Degeneration
  • T-Lymphocytes / immunology

Substances

  • Amyloid beta-Peptides
  • Anti-Inflammatory Agents, Non-Steroidal
  • Complement Membrane Attack Complex